Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1951 1
1955 1
1958 1
1959 1
1961 1
1962 3
1964 1
1965 1
1970 1
1971 4
1972 1
1974 1
1975 1
1978 3
1979 1
1980 3
1982 1
1983 2
1984 2
1985 4
1986 2
1987 3
1988 5
1989 2
1990 5
1991 6
1992 4
1993 7
1994 4
1995 3
1996 8
1997 8
1998 5
1999 4
2000 10
2001 9
2002 7
2003 5
2004 13
2005 21
2006 7
2007 21
2008 25
2009 38
2010 33
2011 45
2012 51
2013 65
2014 63
2015 101
2016 106
2017 116
2018 139
2019 152
2020 199
2021 224
2022 255
2023 256
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

1,855 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Al-Freih
Page 1
Did you mean maia al fresh (1 results)?
Complement in Secondary Thrombotic Microangiopathy.
Palma LMP, Sridharan M, Sethi S. Palma LMP, et al. Kidney Int Rep. 2021 Jan;6(1):11-23. doi: 10.1016/j.ekir.2020.10.009. Epub 2020 Oct 21. Kidney Int Rep. 2021. PMID: 33102952 Free PMC article. Review.
Thrombotic microangiopathy (TMA) is a condition characterized by thrombocytopenia and microangiopathic hemolytic anemia (MAHA) with varying degrees of organ damage in the setting of normal international normalized ratio and activated partial thromboplastin time. ...
Thrombotic microangiopathy (TMA) is a condition characterized by thrombocytopenia and microangiopathic hemolytic anemia (MAHA) with v …
How I treat microangiopathic hemolytic anemia in patients with cancer.
Thomas MR, Scully M. Thomas MR, et al. Blood. 2021 Mar 11;137(10):1310-1317. doi: 10.1182/blood.2019003810. Blood. 2021. PMID: 33512445 Free PMC article. Review.
Microangiopathic hemolytic anemia (MAHA) with thrombocytopenia, suggests a thrombotic microangiopathy (TMA), linked with thrombus formation affecting small or larger vessels. ...Drug-induced TMA should be considered and any putative causal agent stopped. We will discuss th …
Microangiopathic hemolytic anemia (MAHA) with thrombocytopenia, suggests a thrombotic microangiopathy (TMA), linked with thrombus for …
Complement-mediated thrombotic microangiopathy associated with lupus nephritis.
Park MH, Caselman N, Ulmer S, Weitz IC. Park MH, et al. Blood Adv. 2018 Aug 28;2(16):2090-2094. doi: 10.1182/bloodadvances.2018019596. Blood Adv. 2018. PMID: 30131343 Free PMC article. Clinical Trial.
It is characterized by thrombocytopenia and microangiopathic hemolytic anemia (MAHA) with microvascular thrombosis resulting in systemic organ damage (TMA). ...A subset of these patients also develop TMA, with progressive life-threatening thrombocytopenia, MAHA, and …
It is characterized by thrombocytopenia and microangiopathic hemolytic anemia (MAHA) with microvascular thrombosis resulting in syste …
MAO Inhibitors.
Sabri MA, Saber-Ayad MM. Sabri MA, et al. 2023 Jun 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. 2023 Jun 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 32491327 Free Books & Documents.
Thrombotic microangiopathy in cancer.
Weitz IC. Weitz IC. Thromb Res. 2018 Apr;164 Suppl 1:S103-S105. doi: 10.1016/j.thromres.2018.01.014. Epub 2018 Jan 9. Thromb Res. 2018. PMID: 29703465 Review.
Thrombotic microangiopathy (TMA) is clinical syndrome based on the presence of thrombocytopenia (platelet count <150 K or a reduction of the platelet count by >30% from baseline) accompanied by fragmentation hemolysis (MAHA) and evidence of organ damage. It can be se …
Thrombotic microangiopathy (TMA) is clinical syndrome based on the presence of thrombocytopenia (platelet count <150 K or a reduction of …
[Breast cancer-related thrombotic microangiopathy: A review].
Alhenc-Gelas M, Bidard FC. Alhenc-Gelas M, et al. Bull Cancer. 2021 Jul-Aug;108(7-8):730-739. doi: 10.1016/j.bulcan.2021.03.017. Epub 2021 May 26. Bull Cancer. 2021. PMID: 34052032 Review. French.
We conducted a review of all original published cases of TM reported in breast cancer, and we specifically investigated BC-MAHA cases. A Medline search identified 158 MAHA cases including 118 BC-MAHA, and 40 drug-related MAHA. ...Incidence of coagulati …
We conducted a review of all original published cases of TM reported in breast cancer, and we specifically investigated BC-MAHA cases …
Syndromes of Thrombotic Microangiopathy.
Shatzel JJ, Taylor JA. Shatzel JJ, et al. Med Clin North Am. 2017 Mar;101(2):395-415. doi: 10.1016/j.mcna.2016.09.010. Epub 2016 Dec 27. Med Clin North Am. 2017. PMID: 28189178 Review.
Thrombotic microangiopathy and pregnancy.
Koucký M, Toman A, Ryšavá R, Pařízek A. Koucký M, et al. Ceska Gynekol. 2020 Winter;85(1):18-28. Ceska Gynekol. 2020. PMID: 32414281 Review. English.
This syndrome represents a serious pathological condition characterized by microangiopathic haemolytic anemia (MAHA), thrombocytopenia and various organ dysfunction. Patients are most often presented with symptoms of the HELLP syndrome but if the clinical picture is not re …
This syndrome represents a serious pathological condition characterized by microangiopathic haemolytic anemia (MAHA), thrombocytopeni …
Intratumoral injection reduces toxicity and antibody-mediated neutralization of immunocytokine in a mouse melanoma model.
Baniel CC, Sumiec EG, Hank JA, Bates AM, Erbe AK, Pieper AA, Hoefges AG, Patel RB, Rakhmilevich AL, Morris ZS, Sondel PM. Baniel CC, et al. J Immunother Cancer. 2020 Oct;8(2):e001262. doi: 10.1136/jitc-2020-001262. J Immunother Cancer. 2020. PMID: 33115944 Free PMC article.
METHODS: C57BL/6 mice were injected with human IgG or the hu14.18-IL2 IC to develop a mouse anti-human antibody (MAHA) response (MAHA(+)). In vitro assays were performed to assess ADA binding to IC using sera from MAHA(+) and MAHA(-) mice. ...Histamine …
METHODS: C57BL/6 mice were injected with human IgG or the hu14.18-IL2 IC to develop a mouse anti-human antibody (MAHA) response (M …
1,855 results